USSTOCK.TODAY
Market Closed
Log in Sign up

Coherus Oncology Misses Q3 Loss and Revenue Estimates

Associated Press +2 · ·by G4L

CHRS
CHRS Coherus Oncology Inc
$0.82 +6.18%
View chart & analysis →
  1. 1Coherus Oncology, Inc. reported a Q3 loss of $39.3 million on Monday.
  2. 2Coherus Oncology, Inc. revenue of $14.3 million for the period fell below market expectations.
  3. 3The figure was lower than the $15.9 million revenue estimate from 3 analysts surveyed by Zacks.

So what's the key point?

Coherus Oncology, Inc. reported a loss of $39.3 million in the third quarter instead of making a profit. Revenue also came in lower than what experts expected, which is unfavorable news for investors.

Source Associated Press +2 · View original ↗

Related 3-line summaries

PubMatic achieves record results with 17% revenue growth in Q3 The Motley Fool +1 · 18m agoLantronix records $32.4 million in Q1 revenue, maintaining growth trend The Motley Fool +1 · 23m agoAmerican Public Education Beats Q3 Revenue and Net Income Guidance The Motley Fool +1 · 23m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news